ArticleSignal transduction and targeted therapy2026
Alveolar epithelial depletion of βPAK-interacting exchange factor drives spontaneous pulmonary fibrosis by impairing stemness.
Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Aberrant repair/regeneration of alveolar epithelial stem cells is a key driver of pulmonary fibrosis (PF). While βPAK-interacting exchange factor (βPIX) is connected to stem cell signaling, its role in pulmonary fibrosis (PF) remains unknown. Here, we generated conditional βPIX knockout mice to investigate its contribution to PF pathogenesis. Selectively depleting βPIX in alveolar type 2 (AT2) cells led to progressive PF in mice, recapitulating the key features observed in human idiopathic pulmonary fibrosis (IPF), where AT2 cells exhibit significantly reduced βPIX levels. Single-nucleus RNA sequencing of the lungs of βPIX-deficient mice revealed the emergence of progenitor cells in a transitional stem cell state with senescent attributes, along with active, collagen-producing myofibroblasts. Mechanistically, the loss of βPIX impaired AT2 cell stemness by downregulating Wnt/β-catenin signaling. AT2 cells from IPF patients also presented reduced levels of β-catenin and Axin2, confirming the downregulation of Wnt/β-catenin signaling. Treatment with a glycogen synthase kinase-3β inhibitor reactivated Wnt/β-catenin signaling and attenuated fibrosis in βPIX-deficient mice. Our results establish a direct causal link between βPIX deficiency and PF, highlighting βPIX and its downstream pathway as promising therapeutic targets for this devastating disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.